Market Research Logo

Respiratory Care Devices Global Market - Forecast to 2022

Respiratory Care Devices Global Market - Forecast to 2022

Respiratory Care Diagnostic devices are the devices which are used for the diagnosis of respiratory diseases such as Pneumonia, Asthma, Bronchitis, Sleep Apnea, cystic and pulmonary fibrosis, Tuberculosis, COPD (Chronic Obstructive Pulmonary Disease) etc. The Respiratory Care Device global market is segmented based on the products, applications, end-users and geography. Products are divided into Therapeutic device, Monitoring Device, Diagnostic Device and Consumables. Therapeutic devices include humidifiers, nebulizers, oxygen concentrators, Positive airway pressure (PAP) device, resuscitators, ventilators, inhalers and others. Humidifiers are further segmented into passive and active humidifiers. Nebulizers are segmented into jet nebulizers, ultrasonic nebulizers, mesh nebulizers and smart nebulizers. Oxygen concentrators are divided into stationary oxygen concentrators and portable oxygen concentrators. Positive airway pressure devices are further segmented such as continuous positive airway pressure (CPAP) devices, Automatic PAP (APAP) devices, Bi-level PAP devices (BPAP) devices. Resuscitators are classified as manual and gas powered resuscitators. Ventilators are further segmented into non invasive and invasive ventilators. Inhalers are segmented such as dry powdered inhaler and metered dose inhaler. Monitoring device market is segmented into Pulse Oximeters, Capnographs and Gas Analyzers. Pulse Oximeters are further classified into Finger Pulse Oximeters, Handheld Pulse Oximeters, Wrist Pulse Oximeters, and Tabletop Pulse Oximeters. Diagnostic segments are divided into Spirometers, Peak Flow Meters, Polysomnographs device (PSG), where in Spirometers are further classified into Volumetric Spirometers and Flow Measuring Spirometers. PSG devices are classified into Clinical Polysomnographs devices and Ambulatory Polysomnographs devices. Consumables are divided into masks, tracheostomy tubes, nasal cannulas and others. Masks are segmented into Nasal masks, Full face masks, Nasal pillow masks, and Oral masks and others which include Non rebreather masks and Pocket masks.

By application, the Respiratory Care Device markets are divided into Acute Respiratory distress syndrome, asthma, Chronic Obstructive pulmonary diseases, Pulmonary fibrosis, Cystic fibrosis, Pneumonia, Respiratory failure, Restrictive lung diseases, Sleep Apnea and Tuberculosis, Lung Cancer and Others. Chronic Obstructive pulmonary diseases are further divided into chronic bronchitis and emphysema. Based on the end- users they are segmented into hospitals and home healthcare.

Among the Respiratory Care Devices products, therapeutic devices market dominated the products market by occupying a largest share as well as fastest growing segment from 2015 to 2022. In applications, the asthma is the largest market share and COPD is the fastest growing segment from 2015 to 2022. By end- users, hospitals is the largest segment with a share of 52.4% and, home care is the fastest segment with a CAGR from 2015 to 2022.Geographical wise, North America is the largest market, with a share of 45.2% followed by Europe and Asia. The APAC region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Respiratory Care Device market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The Respiratory Care Device market is expected to grow steadily at a high single digit CAGR from 2015 to 2022. The factors driving the growth of this market are increasing incidences of respiratory diseases such as Respiratory failure, COPD, asthma, sleep apnea, cystic fibrosis, Pneumonia, Tuberculosis etc. Urbanization and increasing pollution is one of the factor driving the respiratory care device market, new technology products boosting respiratory care device products market growth, increase in aging population, Increasing prevalence of tobacco usage, Increasing preterm birth incidence, rising use of non invasive ventilators and government initiatives and wide range of available products likely to propel the respiratory care device market. In addition to this, Growing Demand for Home Care Therapeutic Devices, Huge Pool of Undiagnosed Sleep Apnea Patients, Increasing COPD, leading to increasing the requirement of ventilators, healthy growth in the innovative products and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, Lack of awareness of the disease, Large Under diagnosed and Undertreated Population, Harmful Effects of Certain Devices on Neonates and reluctance in adoption of new technologies are hampering the growth of the market. The threats for the respiratory care device market include Availability of low cost products from local manufacturers, stringent regulations for approval and mandatory licensing for Practitioners and Reimbursement issues.

The Respiratory Care Device global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the respiratory care device market are Becton Dickinson and Company (Care Fusion) (U.S.), Chart Industries (U.S.), Drager Medical AG & Co. KGaA (Germany), Fisher & Paykel Healthcare (New Zealand), GE Healthcare (U.K.), Invacare Corporation (U.S.), Gettinge Groups (Sweden), Medtronic PLC (Ireland), Philips Healthcare (Netherlands) and Resmed, Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
North America
Europe
Asia-Pacific
Rest of the World (RoW)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rising incidences of respiratory diseases
3.3.1.2 Urbanization and increasing pollution
3.3.1.3 Increasing prevalence of tobacco usage
3.3.1.4 Increasing preterm birth incidence
3.3.1.5 Rising use of non invasive ventilators
3.3.1.6 Growing demand for home care therapeutic devices
3.3.1.7 Huge pool of undiagnosed sleep apnea patients
3.3.1.8 Increasing COPD, leading to increasing the requirement of respiratory care therapy
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Lack of awareness of the disease
3.3.2.2 Large Under diagnosed and Undertreated Population
3.3.2.3 Harmful effects of certain devices on neonates
3.3.2.4 Availability of low cost products from local manufacturers
3.3.2.5 Stringent regulations for approval and mandatory licensing for respiratory therapist
3.3.2.6 Reimbursement issues
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 INDIA
3.4.4 CHINA
3.4.5 JAPAN
3.5 REIMBURSEMENT
3.6 SUPPLY CHAIN ANALYSIS
3.7 TECHNOLOGICAL ADVANCEMENTS
3.7.1 DUBBED COUGHAWARE FROM QUVIUM & DSP CONCEPTS
3.7.2 CHEST WALL MOTION ASSESSMENT SYSTEM FROM UNIVERSITY OF WARWICK
3.7.3 THE HEALTH AND ENVIRONMENTAL TRACKER (HET), A WEARABLE SYSTEM OF NANO-ENABLED SENSORS BY RESEARCHERS FROM NORTH CAROLINA STATE UNIVERSITY'S (NCSU)
3.7.4 SMART INHALERS
3.7.5 SMART NEBULIZERS
3.7.6 MASIMO CORPORATION’S RADIUS-7 FDA 510(K) CLEARANCE
3.7.7 NONIN MEDICALS (U.S.) LAUNCHED A SMART WIRELESS FINGER PULSE OXIMETER
3.7.8 SMARTDOSE MINI OXYGEN CONSERVER BY DRIVE DEVILBISS
3.7.9 MICRO-CPAP MACHINE
3.8 PORTER’S FIVE FORCE ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 BARGAINING POWER OF BUYERS
3.8.5 COMPETITIVE RIVALRY
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10 PATENT ANALYSIS BY MAJOR PLAYERS
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 THERAPEUTICS DEVICES
4.2.1 HUMIDIFIERS
4.2.1.1 Active Humidifiers
4.2.1.2 Passive Humidifiers
4.2.2 NEBULIZERS
4.2.2.1 Jet Nebulizer
4.2.2.2 Ultrasonic Nebulizer
4.2.2.3 Mesh Nebulizer
4.2.2.4 Smart Nebulizers
4.2.3 OXYGEN CONCENTRATORS
4.2.3.1 Stationary Oxygen Concentrators
4.2.3.2 Portable Oxygen Concentrators
4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP)
4.2.4.1 Continuous PAPDevices (CPAP)
4.2.4.2 Automatic PAP (APAP) Devices
4.2.4.3 Bi-Level PAP (BPAP) Devices
4.2.5 RESUSCITATORS
4.2.5.1 Manual Resuscitator
4.2.5.2 Gas Powdered Resuscitator
4.2.6 VENTILATORS
4.2.6.1 Non-Invasive Ventilators
4.2.6.2 Invasive Ventilators
4.2.7 INHALERS
4.2.7.1 Dry Powder Inhalers
4.2.7.2 Metered Dose Inhaler
4.2.8 OTHERS
4.2.8.1 Positive Expiratory Pressure Device (PEP)
4.2.8.2 Nitric Oxide Delivery Unit
4.2.8.3 Oxygen Hood
4.2.8.4 Flutter Valve Device
4.2.8.5 Nasal Cornet
4.2.8.6 Intrapulmonary Percussive Ventilator
4.2.8.7 Cardiopulmonary Resuscitation Emergency Kit
4.2.8.8 High Frequency Chest Wall Oscillation Device (HFCWO)
4.2.8.9 Diaphragm Pacing
4.3 MONITORING DEVICES
4.3.1 PULSE OXIMETERS
4.3.1.1 Finger Pulse Oximeters
4.3.1.2 Handheld Pulse Oximeters
4.3.1.3 Wrist Pulse Oximeters
4.3.1.4 Tabletop Pulse Oximeters
4.3.2 CAPNOGRAPHS
4.3.3 GAS ANALYZERS
4.4 DIAGNOSTIC DEVICES
4.4.1 SPIROMETERS
4.4.1.1 Volumetric Spirometers
4.4.1.2 Flow Measuring Spirometers
4.4.2 PEAK FLOW METERS
4.4.3 POLYSOMNOGRAPH DEVICES (PSG)
4.4.3.1 Clinical Polysomnograph Devices
4.4.3.2 Ambulatory Polysomnographs Devices
4.5 CONSUMABLES
4.5.1 MASKS
4.5.1.1 Nasal Masks
4.5.1.2 Full Face Mask
4.5.1.3 Nasal Pillow Masks
4.5.1.4 Nasal Oral Masks
4.5.1.5 OTHERS
4.5.2 TRACHEOSTOMY TUBE
4.5.3 NASAL CANNULAS
4.6 OTHERS
5 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 ACUTE RESPIRATORY DISTRESS SYNDROME
5.3 ASTHMA
5.4 CHRONIC OBSTRUCTIVE PULMANARY DISEASE (COPD)
5.4.1 CHRONIC BRONCHITIS
5.4.2 EMPHYSEMA
5.5 CYSTIC FIBROSIS
5.6 PULMONARY FIBROSIS
5.7 PNEUMONIA
5.8 RESPIRATORY FAILURE
5.9 SLEEP APNEA
5.10 TUBERCULOSIS
5.11 LUNG CANCER
5.12 OTHERS
6 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME HEALTH CARE
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 EUROPE
7.2.3 ASIA PACIFIC
7.2.4 REST OF THE WORLD
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 NEW PRODUCT LAUNCH AS MAJOR GROWTH STRATEGY OF RESPIRATORY CARE DEVICE MARKET PLAYERS
8.2 NEW PRODUCT LAUNCH
8.3 MERGERS AND ACQUISITION
8.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
8.5 APPROVAL
8.6 OTHERS
9 MAJOR PLAYERS PROFILES
9.1 BECTON, DICKINSON AND COMPANY (CAREFUSION CORPORATION)
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 CHART INDUSTRIES, INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 DRAGER MEDICAL AG & CO. KGAA
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 GE HEALTHCARE
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 GETINGE GROUPS (MAQUET GMBH & CO. KG)
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 INVACARE CORPORATION
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MEDTRONIC INC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 PHILIPS HEALTHCARE
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 RESMED CORP
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report